LYEL
Lyell Immunopharma Inc
9.10$
-2.1%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Cash Flow
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -3.00 | -3.21 | -3.31 | -2.98 | -2.73 | -3.54 | -3.71 | -2.33 | -1.56 | -1.89 | -1.76 | -1.45 | -5.70 | |
| 0.41 | 0.40 | 0.40 | 0.38 | 0.37 | 0.38 | 0.23 | 0.21 | 0.14 | 0.14 | 0.11 | 0.10 | 0.41 | |
| 0.84 | 0.67 | 0.72 | 0.65 | 0.59 | 0.61 | 0.41 | 0.34 | 0.29 | 1.50 | 0.20 | 0.19 | 1.70 | |
| 0.19 | 0.14 | -0.25 | -0.07 | 0.08 | 0.00 | -0.65 | -0.06 | -0.01 | 0.04 | -0.05 | 0.34 | 0.31 | |
| 0.02 | 0.00 | 0.00 | 0.03 | 0.00 | 0.00 | 0.02 | 0.01 | 0.00 | 0.02 | 0.00 | 0.01 | 0.03 | |
| 7.93 | -7.96 | 1.73 | 3.52 | 0.15 | 4.01 | 4.71 | 0.85 | 0.18 | -1.83 | 0.79 | 0.67 | 0.21 | |
| -0.02 | -0.01 | -0.01 | 0.06 | -0.06 | 2.70 | – | – | – | – | – | – | – | |
| -0.01 | 0.06 | 0.00 | 0.07 | 0.00 | 0.03 | 0.00 | 0.01 | 2.74 | 0.01 | 2.36 | 0.02 | 4.39 | |
| 4.92 | -11.11 | -1.57 | 0.61 | -2.58 | 0.40 | 1.00 | -1.46 | 1.36 | -3.71 | 1.40 | -0.76 | -1.11 | |
| -3.01 | -3.21 | -3.31 | -3.01 | -2.74 | -3.55 | -3.73 | -2.34 | -1.57 | -1.90 | -1.76 | -1.46 | -5.73 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.